Back pain
Inossia – a glimmer of light in a dark financing climate
In a still challenging financial climate with lowered company valuations, investors are looking for glimmers of light to dare to believe in a...
Newly appointed CMO sees opportunities in Stayble Therapeutics
The Gothenburg-based pharmaceutical company Stayble Therapeutics recently announced that...
Intervju
BioStock Investor Pitch: Stayble Therapeutics expands operations
Stayble Therapeutics expands the use of the company's drug candidate STA363...
Intervju
Video
Stayble Therapeutics treats the underlying cause of back pain
The idea of connective tissue transforming a spinal disc to prevail...